India's PharmEasy Aims to Make Drugs More Accessible: Co-Founder

(3:55)

PharmEasy (API-Holdings) Deep Dive | PharmEasy Unlisted Shares | PharmEasy Share Price 2022

(42:58)

Is Pharma the next Big Industry in India? Raj Shamani #shorts

(29)

PharmEasy's Exapnsion Plans | NDTV Profit

(5:3)

PharmEasy is Near Death - Ashneer Grover | PharmEasy new funding round ‘sudden death’ Ashneer Grover

(8:30)

😰 😰 😰

(9)

40 APIs Every Developer Should Use (in 12 minutes)

(12:23)

API Design 101: From Basics to Best Practices

(5:39)

How To Create a Python API With FastAPI - Full Tutorial

(25:39)

APIs Explained (in 4 Minutes)

(3:57)

Rs 20 हज़ार में लें Pharmeasy franchise business | Pharmacy franchise business/ business ideas

(7:59)

Why doctors Don’t prescribe generic medicines %

(1:1econd)

Demystifying Unlisted Stocks: Understanding the Market of Unlisted Shares \u0026 Their Risks and Rewards

(9:49)

Pharmeasy Founder Siddharth Shah Is Preparing For A Big IPO But It Wasn't All Sunshine And Roses

(2:59)

Manufacturing of API ( ACTIVE PHARMACEUTICAL INGREDIENT)

(5:39)

Build your first API in 10 minutes | API tutorial | FastAPI tutorial | Build API from scratch

(12:13)

What is API Holding Rights Issue? | Pharmeasy | Rights Issue explained

(3:21)

Unboxing medicines from pharmeasy #unboxing #pharmeasy #medicines #onlinepharmacy

(59)

PharmEasy

(16)

FIRESIDE CHAT: EMPOWERING SELF CARE THROUGH PHYGITAL: A GREAT FUTURE FOR HEALTHCARE

(31:50)

API Holdings: We can become profitable soon but choose to continue investing in tech for future grow

(1:20)

My 2nd pharmEasy haul buy all products what u needed #shorts#pharmeasy

(24)

Which company has invested in API Holdings (@PharmEasyApp)? | Pharmeasy Unlisted Shares | Planify

(1:1econd)

Pharmeasy Summary | Buy Pharmeasy Unlisted Shares

(2:23)

PharmEasy (API Holdings) Unlisted Shares | PharmEasy Analysis | PharmEasy Unlisted Share Price!

(56)

API Active Pharmaceutical Ingredients

(47)

Scientific and Regulatory Considerations for API Drug Development

(1:1:36)

Pharmeasy Founder Siddharth Shah On ₹3,950 Cr Rights Issue Oversubscribed, IPO Plans | CNBC TV18

(20:33)

Why PharmEasy Is Accepting Fresh Funds At ~90% Valuation Cut? | Business 360 | CNBC TV18

(3:16)

When Debt Gets Repaid, The Thyrocare Pledge Will Come Down: PharmEasy CEO Siddharth Shah

(11:29)